United Kingdom · 
What does Cazenove Capital invest in?
Cazenove Capital invests most often at Series B and Growth (50% of the rounds on record), in sectors such as Biotechnology and Genetics.
Cazenove Capital highlights
- 01
12 rounds on record
- 02
Mostly Series B and Growth: 50% of its rounds
- 03
3 exits from the portfolio
What they do
- Type
- Wealth manager (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyGenetics
- Based in
- London, United Kingdom
- Cold pitches
- Not stated
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
The record
Every round we can evidence, newest first12 appearances
- 2012
1 round
- Jun
- 2007
1 round
- Sept
- 2006
4 rounds
- May
- Mar
- Mar
- Mar
- 2005
2 rounds
- Mar
- Jan
- 2004
1 round
- Jun
- 2002
1 round
- Aug
- 2001
2 rounds
- Nov
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
WANdiscoListedUndisclosedSept 2012
ZeusBought by Riverbed Technology$110MJul 2011
Powerlase PhotonicsBought by EO TechnicsUndisclosedSept 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.